Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gut Microbiota Profiling in Patients With Monoclonal Gammopathy: Implications for Disease Pathogenesis and Progression

NCT06690593 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.

NCT NCT06690593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06690593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gut Microbiota Profiling in Patients With Monoclonal Gammopathy: Implications for Disease Pathogenesis and Progression
Lead sponsor
Zhujiang Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 26, 2024
Completion date
December 30, 2026
Enrollment
2,990 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intestinal flora, m-protein, monoclonal gammopathy of undetermined significance (mgus), multiple myeloma